ÂÜÀòÂÒÂ×

Elli Papaemmanuil is a prominent figure in the field of computational oncology and precision medicine, currently serving as Co-Founder and CEO of Isabl since December 2020. In addition to this role, Elli holds the position of Associate Professor at MSKCC and has been actively involved in scientific advisory boards and consulting within the pharmaceutical sector, focusing on genomic applications and data analytics. Elli’s academic contributions have been recognized through positions such as Junior Team Leader at the University of Cambridge and Senior Postdoctoral Research Fellow at the Wellcome Trust Sanger Institute. With a solid educational background, including a PhD in Human Population Genetics focused on Colorectal Cancer Genomics from the University of London and postdoctoral studies at the University of Cambridge, Elli has established a strong reputation in the genomics community, further supported by experiences from various industry placements and earlier research roles.